Neoplasia/BPH

	State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK). BJUI Compass Aning J, Catto JWF, Martin R, Chatterton K, Mariappan P, Ottley E, Hickey J, McCormack S, Gill S, Szabados B. PMID: 42375995 [PubMed]
	Prostate Cancer: Etiology, Diagnosis, and Treatment. Serican J Med Li C, Li Z, Liu X. PMID: 42375929 [PubMed]
	Holmium versus bipolar en bloc transurethral resection of urinary bladder tumors: a randomized controlled trial. Cent European J Urol Higazy A, Lotfy A, Tawfeek AM, Ali A, Radwan A. PMID: 42375730 [PubMed]
	Does body mass index affect the proper pre-operative grade and stage assessment in patients with prostate cancer undergoing radical prostatectomy? Cent European J Urol Drewa J, Adamowicz J, Juszczak K. PMID: 42375717 [PubMed]
	[Descriptive analytical study of patient survival with vertebral metastases in a rheumatological setting in Togo]. Pan Afr Med J Oniankitan S, Diallo ML, Fianyo E, Ataké AE, Diallo MB, Komi TC, Koffi-Tessio VES, Kakpovi K, Houzou P, Oniankitan O. PMID: 42375555 [PubMed - indexed for MEDLINE]
	Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma. Front Immunol Gambina K, Tymm C, Paiola M, Tanji K, Zech J, Winchester R, Mor A, Gartshteyn Y. PMID: 42375375 [PubMed - indexed for MEDLINE]
	What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. World J Urol Erdem S, Amparore D, Re C, Verep S, Capitanio U, Larcher A, Roussel E, Klatte T, Bertolo R, Muselaers S, Pavan N, Kara O, Ingels A, Pecoraro A, Marchioni M, Pandolfo SD, Diana P, Carbonara U, Mollica V, Warren H, Borregales L, Marandino L, Sharma G, Caliò A, Wu Z, Lovati LA, Ciccarese C, Margue G, Francolini G, Flippot R, Leung DK, Mjaess G, Rosiello G, Mir MC, Palumbo C, Campi R, EAU-YAU Renal Cancer Working Group. PMID: 42373875 [PubMed - indexed for MEDLINE]
	Modified HoLEP technique: does it preserve ejaculation? World J Urol Spezzi Roncero LG, Montelli Yanzi G, Cristallo C, Tirapegui FI, Santillan D, Gonzalez MS. PMID: 42373859 [PubMed - indexed for MEDLINE]
	Circulating metabolite biomarkers associated with prostate cancer risk in Black Americans: findings from the Southern Community Cohort Study. Br J Cancer Yoon HS, Shu XO, Wu J, Sanderson M, Wang X, Wen W, Courtney R, Yang JJ, Blot WJ, Zheng W, Cai Q. PMID: 42373845 [PubMed - as supplied by publisher]
	Reply to Yue Chang's Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404-12. Eur Urol Oncol Contieri R, Hurle R. PMID: 42373419 [PubMed - as supplied by publisher]
	Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis. Eur Urol Viti A, Scuderi S, Cucchiara V, Gandaglia G, Briganti A, Montorsi F. PMID: 42373361 [PubMed - as supplied by publisher]
	Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005. Eur Urol Takahashi T. PMID: 42373360 [PubMed - as supplied by publisher]
	Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs. Sunitinib) for Advanced Renal Cell Carcinoma. Anticancer Res Fujiwara M, Yoshida S, Yajima S, Sato H, Hirakawa A, Fukushima H, Arita Y, Tanaka H, Yokoyama M, Masuda H, Fujii Y. PMID: 42373289 [PubMed - indexed for MEDLINE]
	Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Anticancer Res Ishikawa G, Tamura K, Watanabe K, Matsushita Y, Watanabe H, Motoyama D, Inamoto T. PMID: 42373281 [PubMed - indexed for MEDLINE]
	Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma. Anticancer Res Yen TH, Wang SS, Chen CS, Chen CC, Lin CY, Hung SC, Lai GS, Li JR, Yang CK, Lin YC. PMID: 42373274 [PubMed - indexed for MEDLINE]
	Dual Bipolar Strategy and Postoperative Drain Output in Robot-assisted Radical Nephrectomy. Anticancer Res Miyazaki T, Yamazaki F, Fukuhara Y, Iwata A, Sako R, Miyahara T, Noda K, Yokoyama R, Yamashita S, Fujikawa A, Aso S, Aoyagi C, Tachibana M, Tominaga K, Okabe YU, Gunge N, Haga N. PMID: 42373272 [PubMed - indexed for MEDLINE]
	Insights into Matrix Metalloproteinase-2 Genotypes, Smoking, Alcohol Drinking, Hypertension and Renal Cell Carcinoma in Taiwan. Anticancer Res Chang SY, Tsai HW, Wang BR, Yang YC, Chen JC, Tsai CW, Bau DT, Chang WS. PMID: 42373263 [PubMed - indexed for MEDLINE]
	HSP70: From Molecular Chaperone to Integrative Hub in Castration-Resistant Prostate Cancer Therapeutic Resistance. Eur J Pharmacol Liu Q, Huang T, Li L, Liang Z, Liu Y, Xiao J, Wang X. PMID: 42372934 [PubMed - as supplied by publisher]
	SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial. Lancet Oncol Francolini G, Di Cataldo V, Caini S, Garlatti P, Aquilano M, Bertini N, Bruni A, Ingrosso G, D'Angelillo RM, Tagliaferri L, Jereczek-Fossa BA, Augugliaro M, Triggiani L, Parisi S, Masieri L, Campi R, Valicenti RK, Simontacchi G, Greto D, Bonomo P, Loi M, Tang C, Livi L, ARTO Working Group. PMID: 42372744 [PubMed - indexed for MEDLINE]
	Establishment of a clear cell renal cell carcinoma organoid cohort integrated into the UroCCR clinical database: A feasibility study. Transl Oncol Lefranc R, Waeckel T, Riffet M, Florent R, Desmartin G, Lecouflet L, Divoux J, Poulain L, Tillou X, Weiswald LB, Levallet G, Bazille C. PMID: 42372405 [PubMed - as supplied by publisher]

Articles 1 - 20 / 189285

Page 1 of 9465



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy